Open Access Pre-publication history

Changes in FDA enforcement activities following changes in federal administration: the case of regulatory letters released to pharmaceutical companies

Diane Nguyen, Enrique Seoane-Vazquez, Rosa Rodriguez-Monguio* and Michael Montagne

BMC Health Services Research 2013, 13:27  doi:10.1186/1472-6963-13-27

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 30 Jul 2012
Resubmission - Version 2 Manuscript Author's comment 30 Jul 2012
Reviewer's Report Elaine Morrato 30 Aug 2012
Reviewer's Report Sujit Sansgiry 15 Oct 2012
Resubmission - Version 3 Manuscript Author's comment 18 Nov 2012
Resubmission - Version 4 Manuscript Author's comment 28 Nov 2012
Editorial acceptance 16 Jan 2013
Published 22 Jan 2013